摘要
目的探讨分析妥洛特罗贴剂与普米克令舒雾化吸入联合治疗小儿支气管哮喘的效果。方法选取92例支气管哮喘患儿分为观察组和对照组,对照组进行常规治疗联合普米克令舒雾化吸入治疗,观察组患儿在对照组治疗的基础上给予妥洛特罗贴剂治疗,比较两组患儿临床疗效,临床症状消失时间,治疗前后血常规指标水平及不良反应发生情况。结果治疗后观察组患儿治疗效果总有效率显著高于对照组,观察组患儿咳嗽、气喘、哮鸣音、湿啰音消失时间较对照组患儿显著缩短,治疗后观察组患儿E%较对照组患儿显著降低,差异均具有统计学意义(P<0.05),两组患儿不良反应发生率差异无统计学意义(P>0.05)。结论妥洛特罗贴剂与普米克令舒雾化吸入联合治疗小儿支气管哮喘可显著提高临床疗效,改善患儿临床症状,降低炎症指标,安全性高,值得推广。
Objective: To explore the effect of combination of tiropetil patch and propofol in the treatment of bronchial asthma in children. Methods: Ninety two children with bronchial asthma were selected and divided into the observation group and the control group randomly. In the control group,children were treated with routine therapy combined with pumicrof inhalation,and the children in the observation group were treated with tropicort patch on the basis of the control group. The disappearance of clinical symptoms,the level of blood routine before and after treatment and the occurrence of adverse reactions between the two groups were compared in the clinical efficacy. Results: The total effective rate of the children in the observation group was significantly higher than that in the control group. The children in the observation group had shorter cough,wheezing,wheezing and wet rales disappearance than those in the control group( P〈0. 05). The E% of the children in the observation group were significantly lower than those in the control group. There was no significant difference in the incidence of adverse reactions between the two groups( P〈0. 05). Conclusion: Combination of tiropetol and probucol inhalation in the treatment of pediatric bronchial asthma can significantly improve the clinical efficacy,improve the clinical symptoms of children,and reduce the inflammation index,high safety,which is worthy of spreading in clinical practice.
出处
《泰山医学院学报》
CAS
2017年第11期1238-1240,共3页
Journal of Taishan Medical College